Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Tenax Therapeutics (TENX) Shares Outstanding (Weighted Average) (2016 - 2017)

Tenax Therapeutics' Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $1.4 million for Q3 2017.

  • For Q3 2017, Shares Outstanding (Weighted Average) fell 94.98% year-over-year to $1.4 million; the TTM value through Sep 2017 reached $1.4 million, down 94.98%, while the annual FY2016 figure was $1.4 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2017 was $1.4 million at Tenax Therapeutics, roughly flat from $1.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $28.1 million in Q3 2016 and bottomed at $1.4 million in Q4 2016.
  • The 5-year median for Shares Outstanding (Weighted Average) is $27.7 million (2014), against an average of $16.6 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 1215.48% in 2014 before it plummeted 95.0% in 2016.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.9 million in 2013, then skyrocketed by 467.28% to $28.0 million in 2014, then increased by 0.29% to $28.1 million in 2015, then tumbled by 95.0% to $1.4 million in 2016, then grew by 0.42% to $1.4 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Shares Outstanding (Weighted Average) are $1.4 million (Q3 2017), $1.4 million (Q2 2017), and $1.4 million (Q1 2017).